FinLegal

Introduction

FinLegal is a legal technology platform operated by Litigationware Ltd, a company incorporated in England in July 2018, offering two connected product lines: Medical AI, which turns medical records into structured clinical summaries and chronologies, and Mass & Class Claims, which automates high-volume group litigation, mass tort, and arbitration case administration. The platform operates across the UK, US, Australia, and Europe. No funding or investor information has been publicly disclosed for the company.

Legal Research

FinLegal is not a legal research tool; it focuses on medical-record processing and mass-claims case administration rather than case law or statutory research.

Contract Analysis

The Mass & Class Claims module includes AI document classification and extraction from contracts and claimant statements, but this is a supporting feature of claims processing rather than a dedicated contract-review capability.

Document Drafting

FinLegal does not offer general-purpose document drafting; its output is structured medical summaries and templated cohort communications rather than drafted legal documents.

Legal Translation

No legal translation feature is described on the company's site.

Predictive Analytics

The platform produces confidence-scored medical chronologies and eligibility-check outputs across large claimant cohorts, which offers some analytical structure to case portfolios, though it stops short of predictive outcome modeling.

Pricing

FinLegal uses a pay-per-use pricing model with no subscription required: medical summaries start from £25 per document and document bundles from £150 per bundle, and new firm accounts receive £3,000 in free credit to start, per the company's own pricing page.

User Reviews and Ratings

FinLegal does not yet have an established public review presence on G2 or Capterra.

Verdict

FinLegal is a narrowly focused, pay-as-you-go tool for two specific high-volume workflows — medical record summarization and mass-claims administration — rather than a general legal AI platform. Its transparent per-document pricing is unusual in the category and well-suited to firms running high case volumes with unpredictable staffing needs, but its lack of a public funding history or review track record means buyers should treat it as an early-stage vendor and verify current capabilities directly.